Exchange: NASDAQ·Updated 03:59 PM EDT

TORC resTORbio

$7.46
$0.16
(2.10%)
Today
Closed $7.45
$0.01
(0.13%)
After Hours
Mkt Cap$111.44M
Vol2,686.00

About TORC

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
50

Neutral Sentiment

How do you feel about TORC?

Advertisement|Remove ads.